Document Detail


High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
MedLine Citation:
PMID:  17395309     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Inflammation is one of the key mechanism in the development and progression of coronary artery disease. Myocardial bridging (MB) increases the tendency for development of atherosclerosis. The role of inflammation on the development of atherosclerosis in the MB is not clear. In this study, we investigated the existence of inflammation in the patients who have atherosclerotic plaque in the bridged segment. METHODS: This study included 40 patients (group I) presented with stable angina pectoris and detected MB in LAD on coronary angiography and 30 control subjects (group II) with normal coronary angiogram. Patients in group I were divided into two subgroups based on the findings on intravascular ultrasound (IVUS): group IA included 25 patients without atherosclerotic lesion in any coronary artery and group IB included 15 patients with atherosclerotic lesion in addition to MB in bridged segment of LAD. High-sensitivity C-reactive protein (hs-CRP) levels were compared between group I and II and group IA and IB. RESULTS: IVUS showed an atherosclerotic involvement with the proximal segment of MB in 15 patients (=group IB). No plaques were seen in other coronary arteries, in distal of MB or in the bridged segment. With regards to the level of hs-CRP, while no difference was established between group I and group II (1.7+/-0.4 mg/L vs 1.9+/-0.6 mg/L, p>0.05), hs-CRP was significantly higher in group IB than in group IA (3.2+/-0.3 mg/L vs 1.5+/-0.2 mg/L, p=0.001) and control group (3.2+/-0.3 mg/L vs 1.9+/-0.6 mg/L, p=0.03). A significant positive correlation was detected between the hs-CRP and the percentage of atherosclerotic stenosis on IVUS in group IB (R=0.639, p=0.01). CONCLUSIONS: These results indicate the presence of a low grade inflammation in patients with atherosclerotic lesion in bridged segment.
Authors:
Hamza Duygu; Mehdi Zoghi; Sanem Nalbantgil; Filiz Ozerkan; Cayan Cakir; Faruk Ertas; Umit Yuksek; Azem Akilli; Mustafa Akin; Oktay Ergene
Related Documents :
22335599 - Cxcl13 as a novel marker for diagnosis and disease monitoring in pediatric ptld.
18061689 - Improved therapy and outcome for patients with acute myocardial infarction--data of the...
17593989 - High probability of disease in angina pectoris patients: is clinical estimation reliable?
18713329 - The impact of preinfarction angina on electrocardiographic ischemia grades in patients ...
19646429 - Elevated concentrations of oxidized lipoprotein(a) are associated with the presence and...
10761959 - Are beta-blockers effective in elderly patients who undergo coronary revascularization ...
12576439 - High-dose methotrexate for intraocular lymphoma.
366849 - Medical treatment of the subfertile male.
18328359 - Carnitine deficiency and l-carnitine supplementation in lysinuric protein intolerance.
Publication Detail:
Type:  Letter     Date:  2007-03-28
Journal Detail:
Title:  International journal of cardiology     Volume:  124     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-04     Completed Date:  2008-03-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  267-70     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Angina Pectoris / diagnosis,  etiology
C-Reactive Protein / metabolism*
Case-Control Studies
Chi-Square Distribution
Coronary Angiography
Coronary Artery Disease / diagnosis*,  epidemiology,  etiology
Coronary Vessel Anomalies / complications,  diagnosis*
Female
Follow-Up Studies
Humans
Incidence
Inflammation / blood,  physiopathology
Inflammation Mediators / blood
Male
Middle Aged
Predictive Value of Tests
Probability
Reference Values
Risk Assessment
Sensitivity and Specificity
Severity of Illness Index
Ultrasonography, Interventional
Chemical
Reg. No./Substance:
0/Inflammation Mediators; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of natriuretic peptides in pre-participation screening of college athletes.
Next Document:  The effect of functional performance, respiratory function and osteopenia on the quality of life aft...